BioVie Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6541d35a-934d-44c1-924e-5c3fd67f3e0e/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2026 | $-22.7M | 2025-07-01 – 2026-06-30 | evidence 0001520138-26-000332 |
| FY 2025 | $-18.1M | 2024-07-01 – 2025-06-30 | evidence 0001520138-25-000268 |
| FY 2024 | $-32.2M | 2023-07-01 – 2024-06-30 | evidence 0001520138-24-000324 |
| FY 2023 | $-45.1M | 2022-07-01 – 2023-06-30 | evidence 0001520138-23-000325 |
| FY 2022 | $-27.3M | 2021-07-01 – 2022-06-30 | evidence 0001520138-22-000437 |
| FY 2021 | $-138.1M | 2020-07-01 – 2021-06-30 | evidence 0001520138-21-000509 |
| FY 2020 | $-2.7M | 2019-07-01 – 2020-06-30 | evidence 0001520138-20-000356 |
| FY 2019 | $-2.5M | 2018-07-01 – 2019-06-30 | evidence 0001520138-19-000336 |
| FY 2018 | $-2.4M | 2017-07-01 – 2018-06-30 | evidence 0001520138-18-000269 |
| FY 2017 | $-1.6M | 2016-07-01 – 2017-06-30 | evidence 0001520138-17-000286 |
| FY 2016 | $-432.0k | 2015-07-01 – 2016-06-30 | evidence 0001520138-16-001180 |
| FY 2015 | $-233.4k | 2014-07-01 – 2015-06-30 | evidence 0001520138-16-001180 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).